OpenCMC™ has been designed as an innovation gateway to unlock the commercial potential of the advanced CMC innovation portfolio at the Strathclyde-based CMAC. It aims to build on CMAC’s position as a globally recognised centre of excellence in advanced medicines manufacturing.

CMAC has been named Sustainability Award Winner at the 2026 Scotland’s Life Sciences Awards, a flagship event in the Scottish life sciences calendar. The award celebrates organisations demonstrating long‑term environmental commitment, strong employee and community engagement, and the ability to inspire new ideas and positive change.

ESTAN has the potential to support a wide range of CMAC projects, from crystallisation and formulation to process control and optimisation. It could also be integrated into training programmes, helping to build modelling capability across academic and industrial partners.

The way medicines are developed and made is changing. While drug discovery has become faster, smarter and increasingly data-driven, pharmaceutical manufacturing still faces challenges in flexibility, scalability and efficiency. Bridging this gap between scientific discovery and industrial application is at the heart of CMAC’s mission.

New CMAC research reveals that tablet strength loss at high production speeds is due to increased lubricant distribution from faster feedframe paddle rotation, not compression speed. Using Huxley Bertram’s HB50 simulator, the team isolated variables and replicated industrial conditions.

Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation.

Lonza has joined CMAC as a Translation to Industry Collaborator to enhance its service offering for specialty and enhanced drug product and particle technologies

A new £1m research project to realise the transformative potential of digital technologies like artificial intelligence (AI) in medicines development and manufacturing has been announced.

The Centre of Excellence in Regulatory Science and Innovation (CERSI) project aims to advance regulatory processes by integrating cutting-edge digital technologies.

CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.

Global CDMO Ajinomoto Bio-Pharma Services has become the first organisation to position itself as a Translation to Industry Collaborator within CMAC, a world-leading centre for medicines manufacturing at the University of Strathclyde.

Together, CMAC and digiM will align to accelerate research and development within CMAC’s ambitious strategy for digital transformation of Chemistry, Manufacturing, and Control (CMC) processes.

CMAC launches campaign encouraging postdoctoral researchers from around the globe, to apply for a prestigious Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.

CMAC staff and students recently gathered at the Hilton Dunblane Hydro Hotel for CMAC’s annual Summer School, a week-long event featuring workshops, seminars, and networking opportunities.

The EPSRC MediForge Hub will transform the development and manufacturing of medicines by pioneering an Industry 5.0 manufacturing system for sustainable, resilient, and human-centric medicine production.

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, leon-nanodrugs GmbH (LEON), has proudly announced a pioneering technical evaluation by CMAC, University of Strathclyde.

This ground-breaking CDT is set to revolutionise the pharmaceutical and technology sectors by addressing critical skills needs within the industry.

CMAC are thrilled to announce that we have welcomed Malvern Panalytical as a new Tier 2 member within our cutting-edge technology portfolio.

This collaboration marks a significant milestone for the Centre in driving collaborative research and innovation within advanced pharmaceutical manufacturing.

The University of Strathclyde’s medicines manufacturing research centre, CMAC, is delighted to announce the next phase in our strategic partnership with The Glasgow School of Art (GSA).

14.11.23 CMAC DAY 1